Call 408.493.1800 | Fax 408.493.1801 | Toll Free 800.891.9699 (US Only) | Email: [email protected]

IL-2, human recombinant

based on 2 citations in multiple journalsIL-2, human recombinant24.1 4
A regulator of lymphocyte activities
Catalog #: 4131
SKU-Size Size Price Qty
4131-10 10 μg
$90.00
4131-50 50 μg
$200.00
4131-1000 1 mg
$835.00
More Sizes Get Quote

Product Details

Alternate Name T-cell growth factor (TCGF), Aldesleukin, Lymphokine, IL-2.
Gene Symbol IL2
Gene ID 3553
Accession # P60568
Source E. coli
Appearance Lyophilized protein
Physical Form Description Lyophilized with no additives.
Molecular Weight 15.5 kDa
Purity by SDS-PAGE ≥95%
Purity by ≥95%
Biological Activity The ED50 as determined by the dose-dependent stimulation of murine CTLL-2 cells is < 10 ng/ml, corresponding to a specific activity of > 1 x 10⁵ units/mg.
Reconstitution Instructions Reconstitute in H₂O to a concentration of 0.1-1.0 mg/ml. The solution can then be diluted into other aqueous buffers or stored at 4°C for 1 week or –20°C for future use.
Handling Centrifuge the vial prior to opening.
Storage Conditions -20°C
Shipping Conditions Gel Pack
USAGE For Research Use Only! Not to be used in humans

Details

IL-2 is a potent immuno-modulator, which mediates a wide range of immune and inflammatory responses. Recombinant Human IL-2 is a 15.5 kDa protein containing 134 amino acid residues.


Why buy BioVision Products?
Innovation
Affordability
Global Presence
Technical Support
BioVision aims to provide our customers innovative tools for accelerating drug discovery and biological research. BioVision offers >8,000 products including the most comprehensive array of assay kits for key targets in Metabolic pathways.
BioVision is committed to providing the highest quality products at a competitive price.
We have a broad network of global distributors who are ready to address your research needs and ensure fast delivery.
Our highly trained Technical Support team provides comprehensive product support and is dedicated to resolving your issues quickly and efficiently.
Du et al., CALGB 150905 (Alliance): Rituximab Broadens the Antilymphoma Response by Activating Unlicensed NK Cells. Cancer Immunology, Sep 2014; 2: 878 - 889.
Schneiders et al., CD1d-Restricted Antigen Presentation by VDescription: {gamma}9VDescription: {delta}2-T Cells Requires Trogocytosis. Cancer Immunology, Aug 2014; 2: 732 - 740.
For more citations of this product click here